{"recordsFiltered":48602,"recordsTotal":48602,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=registry_id&start=37800","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=registry_id&start=37200","results":[{"registry_id":"NCT06434948","publication_url":"https://clinicaltrials.gov/study/NCT06434948","title":"The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery: a Prospective, Randomized, Controlled Trial","has_exemption":false,"start_date":"2026-03-03","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05318729","publication_url":"https://clinicaltrials.gov/study/NCT05318729","title":"Application of a Unique Vibration Modality for Postoperative Pain Control in Patients With Distal Radius Fractures to Reduce Postoperative Pain and Opioid Use","has_exemption":false,"start_date":"2026-03-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07178210","publication_url":"https://clinicaltrials.gov/study/NCT07178210","title":"Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease - A Global, Prospective, Early Feasibility Study in Alzheimer's Patients","has_exemption":false,"start_date":"2026-03-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"MMI (Medical Microinstruments, Inc.)","sponsor_slug":"mmi-medical-microinstruments-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07456826","publication_url":"https://clinicaltrials.gov/study/NCT07456826","title":"A Phase 4, Multisite, Randomized, Double-Masked, Well-Controlled Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections: The QUELL Study","has_exemption":false,"start_date":"2026-03-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Harrow Inc","sponsor_slug":"harrow-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07534696","publication_url":"https://clinicaltrials.gov/study/NCT07534696","title":"Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy","has_exemption":false,"start_date":"2026-04-10","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06682013","publication_url":"https://clinicaltrials.gov/study/NCT06682013","title":"A Randomized Pilot Study Comparing the Feasibility of Using a Virtual Agent vs. an Off-site Human Agent to Onboard Oncology Patients to a Remote Monitoring Device","has_exemption":false,"start_date":"2026-04-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226583","publication_url":"https://clinicaltrials.gov/study/NCT07226583","title":"Net-IOB & Exercise Toolkit Pilot Trial: Randomized, Crossover Evaluation of a Behavioral Decision Support Advisor to Improve Glycemic Safety During and After Exercise in Adults With Type 1 Diabetes (NEXT)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07464353","publication_url":"https://clinicaltrials.gov/study/NCT07464353","title":"xDot Access Management System Early Feasibility Study for Closure of Large Bore Femoral-Arterial & Venous-Access Sites","has_exemption":false,"start_date":"2026-04-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"xDot Medical, Inc","sponsor_slug":"xdot-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07543380","publication_url":"https://clinicaltrials.gov/study/NCT07543380","title":"A PHASE 3, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN ADULTS CONSIDERED AT HIGH RISK OF SEVERE RSV DISEASE IN JAPAN","has_exemption":false,"start_date":"2026-05-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07557030","publication_url":"https://clinicaltrials.gov/study/NCT07557030","title":"Optimization for Toric Contact Lenses","has_exemption":false,"start_date":"2026-05-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"CooperVision International Limited (CVIL)","sponsor_slug":"coopervision-international-limited-cvil","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07463807","publication_url":"https://clinicaltrials.gov/study/NCT07463807","title":"Phase Ib/II Fixed Duration Study of Teclistamab/Pomalidomide (TP) Versus Carfilzomib/Pomalidomide/Dexamethasone (KPd) in Early Relapse of Multiple Myeloma","has_exemption":false,"start_date":"2026-06-26","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05554419","publication_url":"https://clinicaltrials.gov/study/NCT05554419","title":"Eradicating Measurable Residual Disease in Patients With Acute Myeloid Leukemia (AML) Prior to StEm Cell Transplantation (ERASE): A MyeloMATCH Treatment Trial","has_exemption":false,"start_date":"2026-07-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07250425","publication_url":"https://clinicaltrials.gov/study/NCT07250425","title":"Development of a Novel, Cost-Effective Gait Training Device Utilized at Home for the Neurological Patient Population","has_exemption":false,"start_date":"2026-08-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Healing Innovations","sponsor_slug":"healing-innovations","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02620852","publication_url":"https://clinicaltrials.gov/study/NCT02620852","title":"Enabling a Paradigm Shift: A Preference-Tolerant RCT of Personalized vs. Annual Screening for Breast Cancer (Wisdom Study)","has_exemption":false,"start_date":"2016-08-31","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02896335","publication_url":"https://clinicaltrials.gov/study/NCT02896335","title":"Phase II Trial of Palbociclib and Pembrolizumab in Central Nervous System Metastases","has_exemption":false,"start_date":"2017-02-02","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04253483","publication_url":"https://clinicaltrials.gov/study/NCT04253483","title":"A Pilot Study Comparing High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy in Localized Prostate Cancer","has_exemption":false,"start_date":"2019-07-17","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03696199","publication_url":"https://clinicaltrials.gov/study/NCT03696199","title":"A Prospective, Randomized Trial Evaluating Regional Anesthesia, Long-Acting Local Anesthesia, and Traditional Care for Pain Control of Operatively Treated Ankle Fractures","has_exemption":false,"start_date":"2020-09-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Lahey Clinic","sponsor_slug":"lahey-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04255160","publication_url":"https://clinicaltrials.gov/study/NCT04255160","title":"Impact of Estradiol on Endothelial Function in Peri-Menopausal Women","has_exemption":false,"start_date":"2020-10-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Delaware","sponsor_slug":"university-of-delaware","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04607954","publication_url":"https://clinicaltrials.gov/study/NCT04607954","title":"MC1923 Phase II Clinical Trial of Durvalumab (MEDI4736) and Lurbinectedin in Patients With Relapsed Extensive Stage Small Cell Lung Cancer Previously Treated With Chemotherapy and Immunotherapy","has_exemption":false,"start_date":"2020-12-04","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04310020","publication_url":"https://clinicaltrials.gov/study/NCT04310020","title":"A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients With Borderline Performance Status","has_exemption":false,"start_date":"2021-01-13","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04467983","publication_url":"https://clinicaltrials.gov/study/NCT04467983","title":"Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone","has_exemption":false,"start_date":"2021-02-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04824092","publication_url":"https://clinicaltrials.gov/study/NCT04824092","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Comparing the Efficacy and Safety of Tafasitamab Plus Lenalidomide in Addition to R-CHOP Versus R-CHOP in Previously Untreated, High-intermediate and High-risk Patients With Newly-diagnosed Diffuse Large B-cell Lymphoma (DLBCL)","has_exemption":false,"start_date":"2021-05-11","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04426214","publication_url":"https://clinicaltrials.gov/study/NCT04426214","title":"Neuromodulation and Cognitive Training for Substance Use Disorders","has_exemption":false,"start_date":"2021-07-16","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04497584","publication_url":"https://clinicaltrials.gov/study/NCT04497584","title":"An Investigator-sponsored Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2021-08-04","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03753204","publication_url":"https://clinicaltrials.gov/study/NCT03753204","title":"Salt-Sensitivity and Immunity Cell Activation","has_exemption":false,"start_date":"2021-09-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03980457","publication_url":"https://clinicaltrials.gov/study/NCT03980457","title":"Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke","has_exemption":false,"start_date":"2021-09-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04797286","publication_url":"https://clinicaltrials.gov/study/NCT04797286","title":"Sildenafil for Early Pulmonary Vascular Disease in Scleroderma","has_exemption":false,"start_date":"2021-09-20","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04605263","publication_url":"https://clinicaltrials.gov/study/NCT04605263","title":"Effects of Deep Brain Stimulation (DBS) of the Pedunculopontine Nucleus (PPN) on Gait, Postural Stability, Freezing of Gait (FOG), and Falls","has_exemption":false,"start_date":"2021-11-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"St. Joseph's Hospital and Medical Center, Phoenix","sponsor_slug":"st-josephs-hospital-and-medical-center-phoenix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04120766","publication_url":"https://clinicaltrials.gov/study/NCT04120766","title":"Safety and Modulation of ABCC9 Pathways by Nicorandil for the Treatment of Hippocampal Sclerosis of Aging: SMArT-HS","has_exemption":false,"start_date":"2021-12-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Gregory Jicha, MD, PhD","sponsor_slug":"gregory-jicha-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05066308","publication_url":"https://clinicaltrials.gov/study/NCT05066308","title":"Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation","has_exemption":false,"start_date":"2022-01-04","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05214365","publication_url":"https://clinicaltrials.gov/study/NCT05214365","title":"Physiological Pacing vs.Conventional Pacing in the Prevention of Pacemaker-induced Cardiomyopathy: A Randomized Study","has_exemption":false,"start_date":"2022-02-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Hospital Clinic of Barcelona","sponsor_slug":"hospital-clinic-of-barcelona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05360732","publication_url":"https://clinicaltrials.gov/study/NCT05360732","title":"Redefining The Use Of A FOLFIRINOX-Like Regimen In the Front Line In Older Patients With Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2022-04-22","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05310448","publication_url":"https://clinicaltrials.gov/study/NCT05310448","title":"Tumor Treating Fields: Pilot Study of Adjuvant Treatment for Brainstem Gliomas","has_exemption":false,"start_date":"2022-05-11","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05258357","publication_url":"https://clinicaltrials.gov/study/NCT05258357","title":"Landmark vs. Ultrasound-Assisted Bone Marrow Biopsy Procedure Study","has_exemption":false,"start_date":"2022-05-18","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05041127","publication_url":"https://clinicaltrials.gov/study/NCT05041127","title":"A Phase II Trial of Cetuximab for Patients With Advanced or Metastatic Chordoma","has_exemption":false,"start_date":"2022-05-27","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05327647","publication_url":"https://clinicaltrials.gov/study/NCT05327647","title":"A Phase II Randomized Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2022-06-23","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"CHU de Quebec-Universite Laval","sponsor_slug":"chu-de-quebec-universite-laval","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05111574","publication_url":"https://clinicaltrials.gov/study/NCT05111574","title":"A Randomized Phase II Trial of Adjuvant Nivolumab With or Without Cabozantinib in Patients With Resected Mucosal Melanoma","has_exemption":false,"start_date":"2022-08-11","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05521048","publication_url":"https://clinicaltrials.gov/study/NCT05521048","title":"Doxycycline Injection of Cutaneous Schwannoma in Neurofibromatosis Type 2","has_exemption":false,"start_date":"2022-09-19","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Eye and Ear Infirmary","sponsor_slug":"massachusetts-eye-and-ear-infirmary","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05559164","publication_url":"https://clinicaltrials.gov/study/NCT05559164","title":"STACIE: Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted Therapy","has_exemption":false,"start_date":"2022-09-19","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04965064","publication_url":"https://clinicaltrials.gov/study/NCT04965064","title":"An Open-Label Phase II Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling","has_exemption":false,"start_date":"2022-09-23","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05553457","publication_url":"https://clinicaltrials.gov/study/NCT05553457","title":"MyHand-SCI: A Wearable Robotic Hand Orthosis for C6-C7 Spinal Cord Injury","has_exemption":false,"start_date":"2022-10-04","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05311956","publication_url":"https://clinicaltrials.gov/study/NCT05311956","title":"Delivery of an At-Home Nonpharmacologic Intervention (Transcranial Neurostimulation) to Mitigate Pain in Patients With End Stage Kidney Disease Receiving Hemodialysis","has_exemption":false,"start_date":"2022-10-24","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05655195","publication_url":"https://clinicaltrials.gov/study/NCT05655195","title":"Chronic Treatment of Alzheimer's Disease With Gamma Frequency Stimulation","has_exemption":false,"start_date":"2022-12-14","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Institute of Technology","sponsor_slug":"massachusetts-institute-of-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05548127","publication_url":"https://clinicaltrials.gov/study/NCT05548127","title":"TACTIVE-U: An Interventional Safety and Efficacy Phase 1b/2, Open-label Umbrella Study to Investigate Tolerability, pk, and Antitumor Activity of Vepdegestrant (ARV-471/PF-07850327), an Oral Proteolysis Targeting Chimera, in Combination With Other Anticancer Treatments in Participants Aged 18 Years and Over With ER+ Advanced or Metastatic Breast Cancer, Sub-study A (ARV-471 in Combination With Abemaciclib)","has_exemption":false,"start_date":"2023-02-23","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05689502","publication_url":"https://clinicaltrials.gov/study/NCT05689502","title":"intenSive UpPer Extremity Recovery Program for Chronic Stroke (SUPER)","has_exemption":false,"start_date":"2023-03-20","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05589181","publication_url":"https://clinicaltrials.gov/study/NCT05589181","title":"Safety and Efficacy of High Dose Buprenorphine Induction in Fentanyl Positive Emergency Department Patients","has_exemption":false,"start_date":"2023-04-06","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05796570","publication_url":"https://clinicaltrials.gov/study/NCT05796570","title":"A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies","has_exemption":false,"start_date":"2023-04-19","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Franziska Wachter","sponsor_slug":"franziska-wachter","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05675527","publication_url":"https://clinicaltrials.gov/study/NCT05675527","title":"Outcomes Following Single Injections of Low-dose Platelet-rich Plasma (PRP), High-dose PRP, or Saline in Patients With Glenohumeral OA: a Randomized Controlled Trial","has_exemption":false,"start_date":"2023-05-02","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05512039","publication_url":"https://clinicaltrials.gov/study/NCT05512039","title":"Reduced-dose onabotuLinumtoxinA for Urgency Incontinence Among Elder Females (RELIEF): A Randomized Controlled Comparative Effectiveness Trial With Embedded Qualitative and Costing Analyses","has_exemption":false,"start_date":"2023-05-12","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05761899","publication_url":"https://clinicaltrials.gov/study/NCT05761899","title":"A First-In-Human Clinical Trial of Lentiviral-mediated CSF2RA Gene Transfer/Pulmonary Macrophage Transplantation Therapy of Hereditary Pulmonary Alveolar Proteinosis","has_exemption":false,"start_date":"2023-06-26","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07398261","publication_url":"https://clinicaltrials.gov/study/NCT07398261","title":"Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children","has_exemption":false,"start_date":"2023-08-28","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Menoufia University","sponsor_slug":"menoufia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06001320","publication_url":"https://clinicaltrials.gov/study/NCT06001320","title":"Historical Controlled, Single Center Open Label Pilot Comparing the Effectiveness and Tolerability of De-novo Initiation of Letermovir Versus Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients","has_exemption":false,"start_date":"2023-09-25","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06045962","publication_url":"https://clinicaltrials.gov/study/NCT06045962","title":"Effect of Three vs Seven Day Ureteral Stent Removal After Ureteroscopy on Stent Related Symptoms","has_exemption":false,"start_date":"2023-11-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06062420","publication_url":"https://clinicaltrials.gov/study/NCT06062420","title":"A Phase 2, Randomized, Open-label, Platform Study Using a Master Protocol to Evaluate Novel Immunotherapy Combinations as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck","has_exemption":false,"start_date":"2023-11-14","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05285917","publication_url":"https://clinicaltrials.gov/study/NCT05285917","title":"BrUOG 419 - Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa (PUSHUP)","has_exemption":false,"start_date":"2023-11-15","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Brown University","sponsor_slug":"brown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05487677","publication_url":"https://clinicaltrials.gov/study/NCT05487677","title":"Augmentation of Subscapularis Repair in Total Shoulder Arthroplasty","has_exemption":false,"start_date":"2023-12-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06255223","publication_url":"https://clinicaltrials.gov/study/NCT06255223","title":"An Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Multimodal Radiotherapy in the Treatment of Renal Cell Carcinoma Progressed After Prior Immunotherapy","has_exemption":false,"start_date":"2023-12-15","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Jinling Hospital, China","sponsor_slug":"jinling-hospital-china","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05931393","publication_url":"https://clinicaltrials.gov/study/NCT05931393","title":"Phase 2, Open-label, Single Cohort, Multicenter Trial for Sequential Treatment of High Dose Cabozantinib on/After Progression on Cabozantinib Monotherapy in Advanced Renal Cell Carcinoma (Seq-Cabo)","has_exemption":false,"start_date":"2023-12-20","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06043323","publication_url":"https://clinicaltrials.gov/study/NCT06043323","title":"A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma","has_exemption":false,"start_date":"2024-01-08","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05989802","publication_url":"https://clinicaltrials.gov/study/NCT05989802","title":"Rapid Research in Diagnostics Development for Tuberculosis Network (R2D2 Kids) and Assessing Diagnostics At Point-of-care for Tuberculosis in Children (ADAPT for Kids)","has_exemption":false,"start_date":"2024-01-26","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06346262","publication_url":"https://clinicaltrials.gov/study/NCT06346262","title":"Seizure Rescue Medication (RM) as Part of a Comprehensive Epilepsy Self-management Package of Care","has_exemption":false,"start_date":"2024-03-05","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06070116","publication_url":"https://clinicaltrials.gov/study/NCT06070116","title":"Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis","has_exemption":false,"start_date":"2024-04-05","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06096038","publication_url":"https://clinicaltrials.gov/study/NCT06096038","title":"Administration of T Cells Expressing Chondroitin-Sulfate-Proteoglycan-4 Specific Chimeric Antigen Receptors (CAR) in Subjects With Head and Neck Squamous Cell Carcinoma (HNSCC)","has_exemption":false,"start_date":"2024-04-05","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06323837","publication_url":"https://clinicaltrials.gov/study/NCT06323837","title":"A Phase II Randomized, Double-blind, Placebo-controlled Clinical Trial (RCT) to Evaluate the Ability of Mirtazapine (MZP) to Increase Methamphetamine (MA) Abstinence Among Treatment-seeking Medication for Opioid Use Disorder (MOUD) Adults","has_exemption":false,"start_date":"2024-06-17","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Washington State University","sponsor_slug":"washington-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04876248","publication_url":"https://clinicaltrials.gov/study/NCT04876248","title":"Phase 2 Trial of Belantamab Mafodotin Consolidation Treatment in Patients With Multiple Myeloma and MRD Positivity After Autologous Stem Cell Transplantation","has_exemption":false,"start_date":"2024-08-19","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06307522","publication_url":"https://clinicaltrials.gov/study/NCT06307522","title":"An Open-Label, Dose-Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of MRG-001 in Patients With Alcoholic Hepatitis","has_exemption":false,"start_date":"2024-09-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"MedRegen LLC","sponsor_slug":"medregen-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06248229","publication_url":"https://clinicaltrials.gov/study/NCT06248229","title":"A Single Center, Flexible-Dose, 10-Week, Randomized, Double-Blinded, Placebo-Controlled, Clinical Trial To Study The Efficacy Of Dyanavel XR In Treating Co-Occurring Fatigue In Adults With Attention Deficit/Hyperactivity Disorder (ADHD)","has_exemption":false,"start_date":"2024-09-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Rochester Center for Behavioral Medicine","sponsor_slug":"rochester-center-for-behavioral-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06534047","publication_url":"https://clinicaltrials.gov/study/NCT06534047","title":"Integrating Transcranial Magnetic Stimulation as a Treatment for Nicotine Dependence in the Clinic: A Pragmatic, Hybrid Effectiveness-Implementation Trial","has_exemption":false,"start_date":"2024-09-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Centre for Addiction and Mental Health","sponsor_slug":"centre-for-addiction-and-mental-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06717698","publication_url":"https://clinicaltrials.gov/study/NCT06717698","title":"Efficacy, Safety and Pharmacokinetics of NNC0519-0130 Once Weekly s.c. Versussemaglutide 1.0 mg and Placebo in People With Chronic Kidney Disease, With or Without Type 2 Diabetes, and With Overweight or Obesity: a Proof-of-concept and Dose-finding Study","has_exemption":false,"start_date":"2024-12-02","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06377540","publication_url":"https://clinicaltrials.gov/study/NCT06377540","title":"MT2022-60: A Phase II Study of Pembrolizumab+ BEAM Conditioning Regimen Before Autologous Stem Cell Transplant (ASCT) Followed by Pembrolizumab Maintenance in Patients of Relapsed or Refractory Classic Hodgkin Lymphoma","has_exemption":false,"start_date":"2024-12-04","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06657924","publication_url":"https://clinicaltrials.gov/study/NCT06657924","title":"Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery","has_exemption":false,"start_date":"2025-02-11","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Kristen Ban","sponsor_slug":"kristen-ban","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07075159","publication_url":"https://clinicaltrials.gov/study/NCT07075159","title":"Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing","has_exemption":false,"start_date":"2025-02-28","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Janice Hernandez, MD","sponsor_slug":"janice-hernandez-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06857708","publication_url":"https://clinicaltrials.gov/study/NCT06857708","title":"The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®","has_exemption":false,"start_date":"2025-03-05","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Benjamin T. Miller","sponsor_slug":"benjamin-t-miller","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06580899","publication_url":"https://clinicaltrials.gov/study/NCT06580899","title":"Effectiveness of Continuous Local Infiltration Analgesia Intra-Articular Catheters for Pain Relief in Total Knee Replacement","has_exemption":false,"start_date":"2025-03-14","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"OrthoCarolina Research Institute, Inc.","sponsor_slug":"orthocarolina-research-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06555133","publication_url":"https://clinicaltrials.gov/study/NCT06555133","title":"A Phase II Pilot Study of yttriuM-90 in Combination With capEcitabine and aTezolizumab for oligomEtastatic cOlorectal Cancer With unResectable lIver MeTastasEs (METEORITE)","has_exemption":false,"start_date":"2025-04-07","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Brown University","sponsor_slug":"brown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06510699","publication_url":"https://clinicaltrials.gov/study/NCT06510699","title":"Randomized Clinical Trial to Evaluate the Use of Genotype-based Dosing of Voriconazole","has_exemption":false,"start_date":"2025-04-14","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"The University of Queensland","sponsor_slug":"the-university-of-queensland","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06969326","publication_url":"https://clinicaltrials.gov/study/NCT06969326","title":"Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Women and Infants Hospital of Rhode Island","sponsor_slug":"women-and-infants-hospital-of-rhode-island","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06991231","publication_url":"https://clinicaltrials.gov/study/NCT06991231","title":"The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty - A Randomized Prospective Clinical Trial","has_exemption":false,"start_date":"2025-06-13","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05870800","publication_url":"https://clinicaltrials.gov/study/NCT05870800","title":"Phase II Open-label Trial of Neoadjuvant Immunotherapy (Atezolizumab) in Combination With CAPOX for Resectable Non-metastatic Proficient Mismatch Repair (pMMR) Colon CancER: NICER Study","has_exemption":false,"start_date":"2025-06-15","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07042217","publication_url":"https://clinicaltrials.gov/study/NCT07042217","title":"A Randomized, Double-blind, Parallel-arm, Sham-controlled Trial of ElectraRx Mindfulness Transcranial Direct Current Treatment System (Elect-MDS) for Adults With Major Depressive Disorder","has_exemption":false,"start_date":"2025-07-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Soterix Medical","sponsor_slug":"soterix-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06795763","publication_url":"https://clinicaltrials.gov/study/NCT06795763","title":"Chronic Total Occlusion (CTO) Crossing, Re-entry and Imaging With the Acolyte™ Catheter System in Subjects Undergoing Percutaneous Coronary Interventional (PCI) Procedures","has_exemption":false,"start_date":"2025-08-06","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Elumn8 Medical","sponsor_slug":"elumn8-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06901310","publication_url":"https://clinicaltrials.gov/study/NCT06901310","title":"Effectiveness of Recruitment, Retention Strategies, and Data Collection Quality: A Feasibility Study in Combat Athletes With Mild Traumatic Brain Injury","has_exemption":false,"start_date":"2025-08-07","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Michael Harl","sponsor_slug":"michael-harl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224230","publication_url":"https://clinicaltrials.gov/study/NCT07224230","title":"Physician-Modified Endografts for Complex Aortic Aneurysms and Thoracoabdominal Aneurysm Repair in High-Risk Patients","has_exemption":false,"start_date":"2025-09-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Steven Maximus","sponsor_slug":"steven-maximus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06698809","publication_url":"https://clinicaltrials.gov/study/NCT06698809","title":"Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness (STILL TIRED)","has_exemption":false,"start_date":"2026-01-12","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07184619","publication_url":"https://clinicaltrials.gov/study/NCT07184619","title":"A Phase III, 12-week, Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Determine the Efficacy, Safety, and Tolerability of a Dose of 15 mg Bid of Evenamide as add-on in Patients With Documented Treatment-resistant Schizophrenia, Which is Not Adequately Controlled by a Stable Therapeutic Dose of the Patient's Current Antipsychotic Medication(s)","has_exemption":false,"start_date":"2026-01-23","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Newron Pharmaceuticals SPA","sponsor_slug":"newron-pharmaceuticals-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07424508","publication_url":"https://clinicaltrials.gov/study/NCT07424508","title":"Movement State-Dependent Adaptive Deep Brain Stimulation for Parkinson's Disease","has_exemption":false,"start_date":"2026-02-04","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Doris Wang, MD, PhD","sponsor_slug":"doris-wang-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07492420","publication_url":"https://clinicaltrials.gov/study/NCT07492420","title":"MedCline Investigational Study for the Treatment of Mild OSA With Positional Therapy","has_exemption":false,"start_date":"2026-03-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Amenity Health, Inc.","sponsor_slug":"amenity-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07527559","publication_url":"https://clinicaltrials.gov/study/NCT07527559","title":"A Randomized Controlled Study Evaluating the Safety and Effectiveness of the Fuzzle Intraoral Device for Weight Management","has_exemption":false,"start_date":"2026-05-01","completion_date":"2026-09-01","has_results":false,"results_due":false,"sponsor_name":"Fuzzle Operating Co.","sponsor_slug":"fuzzle-operating-co","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04340882","publication_url":"https://clinicaltrials.gov/study/NCT04340882","title":"A Phase 2 Study of Docetaxel, Ramucirumab, and Pembrolizumab for Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade","has_exemption":false,"start_date":"2020-06-05","completion_date":"2026-09-02","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04544111","publication_url":"https://clinicaltrials.gov/study/NCT04544111","title":"Phase II Study of PDR001 in Combination With MAPK Pathway Inhibitors in Patients With Radioiodine-Refractory Thyroid Cancer","has_exemption":false,"start_date":"2020-09-02","completion_date":"2026-09-02","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04484012","publication_url":"https://clinicaltrials.gov/study/NCT04484012","title":"A Phase 2 Study to Evaluate CD19-Specific Chimeric Antigen Receptor (CAR)-T Cells Combined With Acalabrutinib for Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)","has_exemption":false,"start_date":"2020-12-31","completion_date":"2026-09-02","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06137742","publication_url":"https://clinicaltrials.gov/study/NCT06137742","title":"A PHASE 1 / 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SINGLE ESCALATING DOSES OF PF-07868489 IN HEALTHY ADULT PARTICIPANTS AND, ADDITIONALLY, CLINICAL ACTIVITY OF REPEAT DOSES IN PARTICIPANTS WITH PULMONARY ARTERIAL HYPERTENSION","has_exemption":false,"start_date":"2023-11-17","completion_date":"2026-09-02","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06151574","publication_url":"https://clinicaltrials.gov/study/NCT06151574","title":"Beamion LUNG 2: A Phase III, Open-label, Randomized, Active-controlled, Multi-centre Trial Evaluating Orally Administered Zongertinib (BI 1810631) Compared With Standard of Care as First-line Treatment in Patients With Unresectable, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer Harbouring HER2 Tyrosine Kinase Domain Mutations","has_exemption":false,"start_date":"2024-02-09","completion_date":"2026-09-02","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06747416","publication_url":"https://clinicaltrials.gov/study/NCT06747416","title":"A Phase II Multicenter, Open Label Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and PK/PD Profile of Multiple Subcutaneous Injection of KN057 in Male Patients with Severe Hemophilia a or Moderate-to-Severe Hemophilia B with or Without Inhibitors","has_exemption":false,"start_date":"2025-09-02","completion_date":"2026-09-02","has_results":false,"results_due":false,"sponsor_name":"Suzhou Alphamab Co., Ltd.","sponsor_slug":"suzhou-alphamab-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07140653","publication_url":"https://clinicaltrials.gov/study/NCT07140653","title":"Evaluation of Arcuate Incisions for Correcting Pre-Existing Corneal Astigmatism in Combination With the Light Adjustable Lens for Cataract and Refractive Lens Exchange Surgery","has_exemption":false,"start_date":"2025-09-02","completion_date":"2026-09-02","has_results":false,"results_due":false,"sponsor_name":"Center For Sight","sponsor_slug":"center-for-sight","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06118255","publication_url":"https://clinicaltrials.gov/study/NCT06118255","title":"Open-Label, Single-Arm, Phase 3 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome","has_exemption":false,"start_date":"2024-05-21","completion_date":"2026-09-03","has_results":false,"results_due":false,"sponsor_name":"UCB BIOSCIENCES, Inc.","sponsor_slug":"ucb-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03059485","publication_url":"https://clinicaltrials.gov/study/NCT03059485","title":"A Randomized Phase II Clinical Trial of Dendritic Cell/AML Fusion Cell Vaccine Versus Observation in Patients Who Achieve a Chemotherapy-induced Remission","has_exemption":false,"start_date":"2017-06-01","completion_date":"2026-09-04","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06721494","publication_url":"https://clinicaltrials.gov/study/NCT06721494","title":"A Phase 2 Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants With Methamphetamine Use Disorder Not Seeking Treatment Receiving a Single Dose of Methamphetamine","has_exemption":false,"start_date":"2026-02-05","completion_date":"2026-09-04","has_results":false,"results_due":false,"sponsor_name":"Clear Scientific, Inc.","sponsor_slug":"clear-scientific-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04175301","publication_url":"https://clinicaltrials.gov/study/NCT04175301","title":"Pilot Study on Effects of Hydrogen Rich Water on Quality of Life of Patients Treated With Radiotherapy for High Grade Gliomas.","has_exemption":false,"start_date":"2019-10-31","completion_date":"2026-09-05","has_results":false,"results_due":false,"sponsor_name":"Stony Brook University","sponsor_slug":"stony-brook-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04965675","publication_url":"https://clinicaltrials.gov/study/NCT04965675","title":"Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of IV Eptinezumab in Adolescents (12-17 Years) for the Preventive Treatment of Chronic Migraine","has_exemption":false,"start_date":"2021-06-30","completion_date":"2026-09-05","has_results":false,"results_due":false,"sponsor_name":"H. Lundbeck A/S","sponsor_slug":"h-lundbeck-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06730750","publication_url":"https://clinicaltrials.gov/study/NCT06730750","title":"A Phase 1/2a, Multicenter, Open-label, First in Human Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors","has_exemption":false,"start_date":"2025-02-12","completion_date":"2026-09-05","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07212049","publication_url":"https://clinicaltrials.gov/study/NCT07212049","title":"Using Ultrasound as an Alternative to Radiography in Measuring Magnetically Controlled Growing Rods (MCGR) in Tibia and Femur Lengthening Patients","has_exemption":false,"start_date":"2025-09-05","completion_date":"2026-09-05","has_results":false,"results_due":false,"sponsor_name":"Nemours Children's Clinic","sponsor_slug":"nemours-childrens-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05534438","publication_url":"https://clinicaltrials.gov/study/NCT05534438","title":"Stereotactic Body Radiation Therapy (SBRT) to Extend the Benefit of Systemic Therapy in Patients With Solitary Disease Progression","has_exemption":false,"start_date":"2022-09-06","completion_date":"2026-09-06","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06862648","publication_url":"https://clinicaltrials.gov/study/NCT06862648","title":"Pivotal Study of the SUI-100™ for the Treatment of Stress Urinary Incontinence (SUI): A Nonsignificant Risk (NSR) Device (SaHARA) Study","has_exemption":false,"start_date":"2025-03-25","completion_date":"2026-09-08","has_results":false,"results_due":false,"sponsor_name":"Acoustic Wave Cell Therapy, Inc.","sponsor_slug":"acoustic-wave-cell-therapy-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04196465","publication_url":"https://clinicaltrials.gov/study/NCT04196465","title":"Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers(Neo-Chance Study)","has_exemption":false,"start_date":"2019-09-09","completion_date":"2026-09-09","has_results":false,"results_due":false,"sponsor_name":"Asan Medical Center","sponsor_slug":"asan-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05798117","publication_url":"https://clinicaltrials.gov/study/NCT05798117","title":"An Open-label, Multi-center, Phase 1/2 Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Participants With Severe, Refractory Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2023-02-28","completion_date":"2026-09-09","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06741397","publication_url":"https://clinicaltrials.gov/study/NCT06741397","title":"A Phase 2b Single Arm, Repeat Dose Study to Evaluate the Pharmacokinetic Profile, Safety, and Tolerability of A New Formulation of Cabotegravir LA Injected Intramuscularly Q4M in Adolescent and Adult Participants at Risk of HIV Acquisition","has_exemption":false,"start_date":"2024-12-20","completion_date":"2026-09-09","has_results":false,"results_due":false,"sponsor_name":"ViiV Healthcare","sponsor_slug":"viiv-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04200443","publication_url":"https://clinicaltrials.gov/study/NCT04200443","title":"A Phase II Study of Cabozantinib and Temozolomide in Patients With Unresectable or Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas","has_exemption":false,"start_date":"2020-01-14","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04435834","publication_url":"https://clinicaltrials.gov/study/NCT04435834","title":"Cerebral Hemodynamics- ICHOR II","has_exemption":false,"start_date":"2020-06-09","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"Matthew Borzage","sponsor_slug":"matthew-borzage","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05523505","publication_url":"https://clinicaltrials.gov/study/NCT05523505","title":"Bridging the Gap Between Brain Network Science and High-definition Non-invasive Brain Stimulation to Develop a Scalable Adult Literacy Intervention","has_exemption":false,"start_date":"2022-11-07","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University","sponsor_slug":"vanderbilt-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672173","publication_url":"https://clinicaltrials.gov/study/NCT05672173","title":"Phase 2 Study of the Combination of Lisocabtagene Maraleucel, Nivolumab, and Ibrutinib in Richter's Transformation","has_exemption":false,"start_date":"2023-06-02","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05660980","publication_url":"https://clinicaltrials.gov/study/NCT05660980","title":"Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age","has_exemption":false,"start_date":"2024-01-24","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05831202","publication_url":"https://clinicaltrials.gov/study/NCT05831202","title":"SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial","has_exemption":false,"start_date":"2024-08-06","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"Galaxy Therapeutics INC","sponsor_slug":"galaxy-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06855160","publication_url":"https://clinicaltrials.gov/study/NCT06855160","title":"A Phase 3a, Open-Label, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of Intramuscular Administration of an Investigational Varicella Vaccine and Priorix Compared With Subcutaneous Administration of Varivax and Priorix, When Given as a First Dose to Healthy Children 12 to 15 Months of Age","has_exemption":false,"start_date":"2025-04-17","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301385","publication_url":"https://clinicaltrials.gov/study/NCT07301385","title":"Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Feasibility and Safety Study","has_exemption":false,"start_date":"2026-03-11","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"Sharp HealthCare","sponsor_slug":"sharp-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03198026","publication_url":"https://clinicaltrials.gov/study/NCT03198026","title":"Phase II, Single Arm, Open Label Multi-center Study of Obinutuzumab and Ibrutinib in the Front Line Treatment of Indolent Non-Hodgkin's Lymphomas","has_exemption":false,"start_date":"2018-02-20","completion_date":"2026-09-11","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05996003","publication_url":"https://clinicaltrials.gov/study/NCT05996003","title":"A Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NS-089/NCNP-02 in Boys With Duchenne Muscular Dystrophy (DMD)","has_exemption":false,"start_date":"2024-02-22","completion_date":"2026-09-11","has_results":false,"results_due":false,"sponsor_name":"NS Pharma, Inc.","sponsor_slug":"ns-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06431373","publication_url":"https://clinicaltrials.gov/study/NCT06431373","title":"A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis","has_exemption":false,"start_date":"2024-09-11","completion_date":"2026-09-11","has_results":false,"results_due":false,"sponsor_name":"Priovant Therapeutics, Inc.","sponsor_slug":"priovant-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03417388","publication_url":"https://clinicaltrials.gov/study/NCT03417388","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","has_exemption":false,"start_date":"2018-02-09","completion_date":"2026-09-14","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04634877","publication_url":"https://clinicaltrials.gov/study/NCT04634877","title":"A Phase 3, Randomized, Double-Blind Study of Pembrolizumab Versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for the Treatment of Newly Diagnosed High-Risk Endometrial Cancer After Surgery With Curative Intent (KEYNOTE-B21 / ENGOT-en11 / GOG-3053)","has_exemption":false,"start_date":"2021-01-10","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05800366","publication_url":"https://clinicaltrials.gov/study/NCT05800366","title":"A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma","has_exemption":false,"start_date":"2023-04-06","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Jennifer Crombie, MD","sponsor_slug":"jennifer-crombie-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06471829","publication_url":"https://clinicaltrials.gov/study/NCT06471829","title":"A Phase II, Multi-site, Open-label, Dose-titration Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Lu AG13909 in Adults With Cushing's Disease","has_exemption":false,"start_date":"2024-06-19","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"H. Lundbeck A/S","sponsor_slug":"h-lundbeck-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06449378","publication_url":"https://clinicaltrials.gov/study/NCT06449378","title":"Multi-center, Single-arm, Prospective Study of Transorb™ Self-Gripping REsorbable Mesh in High-risk subjeCts Undergoing Open Repair of VEntral heRnia","has_exemption":false,"start_date":"2024-07-02","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Medtronic - MITG","sponsor_slug":"medtronic-mitg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06053255","publication_url":"https://clinicaltrials.gov/study/NCT06053255","title":"Safety and Efficacy of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis","has_exemption":false,"start_date":"2024-09-13","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"FUSMobile Inc.","sponsor_slug":"fusmobile-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06113211","publication_url":"https://clinicaltrials.gov/study/NCT06113211","title":"Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06665971","publication_url":"https://clinicaltrials.gov/study/NCT06665971","title":"Effect of Dupilumab on Esophageal Peristaltic Function in Participants with Eosinophilic Esophagitis","has_exemption":false,"start_date":"2024-11-10","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06689254","publication_url":"https://clinicaltrials.gov/study/NCT06689254","title":"REVERSE: a Randomized Controlled Trial (RCT) to Ameliorate Treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) Antagonism","has_exemption":false,"start_date":"2024-11-15","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Christiaan Vinkers","sponsor_slug":"christiaan-vinkers","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06807463","publication_url":"https://clinicaltrials.gov/study/NCT06807463","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2a Trial to Characterize the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease While Undergoing Oral Gluten Exposure","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Teva Branded Pharmaceutical Products R&D LLC","sponsor_slug":"teva-branded-pharmaceutical-products-rd-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07151729","publication_url":"https://clinicaltrials.gov/study/NCT07151729","title":"Use of Anodal Transcranial Direct Current Stimulation to Enhance Upper Limb Recovery in Stroke","has_exemption":false,"start_date":"2025-09-01","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Tan Tock Seng Hospital","sponsor_slug":"tan-tock-seng-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214415","publication_url":"https://clinicaltrials.gov/study/NCT07214415","title":"Evaluating the Effects of Hyperbaric Oxygen Therapy on Cognitive Function, Mental Health, and Quality of Life in Veterans","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Summit Hyperbarics and Wellness","sponsor_slug":"summit-hyperbarics-and-wellness","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06632379","publication_url":"https://clinicaltrials.gov/study/NCT06632379","title":"AtorvaStatin Postpartum and Reduction of Cardiovascular risK (SPARK): A Randomized Placebo-controlled Trial of Atorvastatin Postpartum for Reduction of Cardiovascular Risk","has_exemption":false,"start_date":"2025-10-03","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07318792","publication_url":"https://clinicaltrials.gov/study/NCT07318792","title":"Evaluation of the Safety and the Clinical Effectiveness of Using Tropocells® Autologous PRF System to Treat Chronic, Non-healing, Non-infected Wounds in Combination With Standard of Care (SOC).","has_exemption":false,"start_date":"2026-01-01","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Estar Medical dba Medical Technologies, LTD","sponsor_slug":"estar-medical-dba-medical-technologies-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07517237","publication_url":"https://clinicaltrials.gov/study/NCT07517237","title":"Combining At-Home Transcutaneous Auricular Vagus Nerve Stimulation and Computerized Cognitive Training for Neurocognitive Rehabilitation","has_exemption":false,"start_date":"2026-03-12","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04353778","publication_url":"https://clinicaltrials.gov/study/NCT04353778","title":"Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV","has_exemption":false,"start_date":"2020-08-03","completion_date":"2026-09-16","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05910619","publication_url":"https://clinicaltrials.gov/study/NCT05910619","title":"Transcranial Pulse Stimulation of the Brain in Older Adults With and Without Mild Dementia","has_exemption":false,"start_date":"2024-02-16","completion_date":"2026-09-16","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06832410","publication_url":"https://clinicaltrials.gov/study/NCT06832410","title":"A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of VX-880 in Subjects With Type 1 Diabetes With a Kidney Transplant","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-09-17","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07213154","publication_url":"https://clinicaltrials.gov/study/NCT07213154","title":"Assessment of Novel Label-free Optical Imaging Technology for the Evaluation of Skin Lesions","has_exemption":false,"start_date":"2025-10-15","completion_date":"2026-09-17","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226375","publication_url":"https://clinicaltrials.gov/study/NCT07226375","title":"Comparison of Endoscopic Tissue Cutting and Abdominal Extraction Device With Conventional Cold Scalpel","has_exemption":false,"start_date":"2025-11-13","completion_date":"2026-09-17","has_results":false,"results_due":false,"sponsor_name":"Ege University","sponsor_slug":"ege-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03162536","publication_url":"https://clinicaltrials.gov/study/NCT03162536","title":"A Phase 1/2 Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ARQ 531 in Selected Subjects With Relapsed or Refractory Hematologic Malignancies","has_exemption":false,"start_date":"2017-06-26","completion_date":"2026-09-18","has_results":false,"results_due":false,"sponsor_name":"ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)","sponsor_slug":"arqule-inc-a-subsidiary-of-merck-sharp-dohme-llc-a-subsidiary-of-merck-co-inc-rahway-nj-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04237623","publication_url":"https://clinicaltrials.gov/study/NCT04237623","title":"Phase II Trial Evaluating the Efficacy and Safety of Sargramostim Post-Infusion of T-Replete HLA Mismatched Peripheral Blood Haploidentical Hematopoietic Stem Cells and With Post Transplant Cyclophosphamide","has_exemption":false,"start_date":"2020-05-18","completion_date":"2026-09-18","has_results":false,"results_due":false,"sponsor_name":"Northside Hospital, Inc.","sponsor_slug":"northside-hospital-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03843463","publication_url":"https://clinicaltrials.gov/study/NCT03843463","title":"Escitalopram and Language Intervention for Subacute Aphasia (ELISA)","has_exemption":false,"start_date":"2021-07-18","completion_date":"2026-09-18","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06233461","publication_url":"https://clinicaltrials.gov/study/NCT06233461","title":"A Phase 2b, Multicenter, Randomized, Double-Blind Induction, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Oral TAK-279 in Subjects With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2024-03-05","completion_date":"2026-09-18","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07145333","publication_url":"https://clinicaltrials.gov/study/NCT07145333","title":"Explore the Relationship Between Single Nucleotide Polymorphisms and Topotecan Response and Toxicity in Patients With Small Cell Lung Cancer.","has_exemption":false,"start_date":"2025-08-12","completion_date":"2026-09-18","has_results":false,"results_due":false,"sponsor_name":"Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair","sponsor_slug":"han-xu-md-phd-fapcr-sponsor-investigator-irb-chair","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06145373","publication_url":"https://clinicaltrials.gov/study/NCT06145373","title":"An Open-label, Single-arm Treatment Study to Investigate the Safety and Tolerability of Switching From Emicizumab to Fitusiran Prophylaxis in Male Participants Aged ≥12 Years of Age With Severe Hemophilia A, With or Without Inhibitors","has_exemption":false,"start_date":"2024-03-01","completion_date":"2026-09-19","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05593237","publication_url":"https://clinicaltrials.gov/study/NCT05593237","title":"A Pilot Trial of Longitudinal Repetitive Transcranial Magnetic Stimulation (rTMS) for Chronic Neuropathic Pain","has_exemption":false,"start_date":"2022-04-25","completion_date":"2026-09-20","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05240014","publication_url":"https://clinicaltrials.gov/study/NCT05240014","title":"Enhancing Voluntary Motion in Broad Patient Populations With Modular Powered Orthoses","has_exemption":false,"start_date":"2022-07-29","completion_date":"2026-09-20","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03312556","publication_url":"https://clinicaltrials.gov/study/NCT03312556","title":"Treatment of Supine Hypertension in Autonomic Failure With Continuous Positive Airway Pressure","has_exemption":false,"start_date":"2017-09-21","completion_date":"2026-09-21","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06719739","publication_url":"https://clinicaltrials.gov/study/NCT06719739","title":"Clinical Outcomes in Cataract Patients With Macular Epiretinal Membrane After Implantation of Functional Intraocular Lenses","has_exemption":false,"start_date":"2024-09-21","completion_date":"2026-09-21","has_results":false,"results_due":false,"sponsor_name":"Eye & ENT Hospital of Fudan University","sponsor_slug":"eye-ent-hospital-of-fudan-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06585787","publication_url":"https://clinicaltrials.gov/study/NCT06585787","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease","has_exemption":false,"start_date":"2024-09-26","completion_date":"2026-09-21","has_results":false,"results_due":false,"sponsor_name":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","sponsor_slug":"karuna-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06643481","publication_url":"https://clinicaltrials.gov/study/NCT06643481","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled Parallel Group Study of VHB937 in Amyotrophic Lateral Sclerosis (ALS) Over 40 Weeks Followed by an Open Label Extension (ASTRALS)","has_exemption":false,"start_date":"2024-10-17","completion_date":"2026-09-21","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06708299","publication_url":"https://clinicaltrials.gov/study/NCT06708299","title":"CardiolRxTM in Recurrent Pericarditis (MAVERIC Phase 3) A Randomized, Double-blind, Placebo-controlled Trial","has_exemption":false,"start_date":"2025-04-07","completion_date":"2026-09-21","has_results":false,"results_due":false,"sponsor_name":"Cardiol Therapeutics Inc.","sponsor_slug":"cardiol-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01909245","publication_url":"https://clinicaltrials.gov/study/NCT01909245","title":"Islet Transplantation Using a T-Cell Depleting Immunosuppression Induction Regimen","has_exemption":false,"start_date":"2013-10-16","completion_date":"2026-09-22","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04370587","publication_url":"https://clinicaltrials.gov/study/NCT04370587","title":"A Phase 1/2a, Open-Label, Dose Escalation and Expansion Study of the Safety and Tolerability of T3011 Administered Via Intratumoral Injection as a Single Agent and in Combination With Intravenous Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2020-09-17","completion_date":"2026-09-22","has_results":false,"results_due":false,"sponsor_name":"ImmVira Pharma Co. Ltd","sponsor_slug":"immvira-pharma-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05992935","publication_url":"https://clinicaltrials.gov/study/NCT05992935","title":"A Phase 1/2, Randomized, Placebo-Controlled, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405, Multivalent Candidate Vaccines to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age","has_exemption":false,"start_date":"2023-08-25","completion_date":"2026-09-22","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05952037","publication_url":"https://clinicaltrials.gov/study/NCT05952037","title":"An Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of the BCL2 Inhibitor Sonrotoclax (BGB-11417) as Monotherapy and in Combination With Zanubrutinib (BGB-3111) in Patients With Waldenström Macroglobulinemia","has_exemption":false,"start_date":"2023-10-23","completion_date":"2026-09-22","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04557449","publication_url":"https://clinicaltrials.gov/study/NCT04557449","title":"A PHASE 1/2A STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND ANTI-TUMOR ACTIVITY OF PF-07220060 AS A SINGLE AGENT AND AS PART OF COMBINATION THERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS","has_exemption":false,"start_date":"2020-09-23","completion_date":"2026-09-23","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04883437","publication_url":"https://clinicaltrials.gov/study/NCT04883437","title":"An Open-Label Phase 2 Trial of Acalabrutinib Plus Obinutuzumab in Patients With Untreated, Low Tumor Burden Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas","has_exemption":false,"start_date":"2021-09-03","completion_date":"2026-09-23","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05296512","publication_url":"https://clinicaltrials.gov/study/NCT05296512","title":"A Phase II Trial of Pembrolizumab and Lenvatinib in Patients With Recurrent or Persistent Clear Cell Carcinoma of the Ovary","has_exemption":false,"start_date":"2022-09-23","completion_date":"2026-09-23","has_results":false,"results_due":false,"sponsor_name":"Elizabeth K. Lee MD","sponsor_slug":"elizabeth-k-lee-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05380921","publication_url":"https://clinicaltrials.gov/study/NCT05380921","title":"Testing a Novel Dry Electrode Headset for Electroencephalography Telehealth","has_exemption":false,"start_date":"2022-10-01","completion_date":"2026-09-25","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281963","publication_url":"https://clinicaltrials.gov/study/NCT07281963","title":"Chilipad Sleep Optimization Study","has_exemption":false,"start_date":"2025-09-25","completion_date":"2026-09-25","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07298369","publication_url":"https://clinicaltrials.gov/study/NCT07298369","title":"Cracking Consciousness Study With Monroe & Neuphoria (Cohort 2&3)","has_exemption":false,"start_date":"2025-09-25","completion_date":"2026-09-25","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04083963","publication_url":"https://clinicaltrials.gov/study/NCT04083963","title":"BRE-01: Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel Followed by Doxorubicin and Cyclophosphamide in Triple Negative Breast Cancer","has_exemption":false,"start_date":"2019-08-09","completion_date":"2026-09-27","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04961567","publication_url":"https://clinicaltrials.gov/study/NCT04961567","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care","has_exemption":false,"start_date":"2021-07-16","completion_date":"2026-09-27","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06066333","publication_url":"https://clinicaltrials.gov/study/NCT06066333","title":"Safety and Immunological Effects of Pembrolizumab Plus Ablative Radiotherapy in Patients With Advanced Adrenocortical Carcinoma","has_exemption":false,"start_date":"2023-09-27","completion_date":"2026-09-27","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02194738","publication_url":"https://clinicaltrials.gov/study/NCT02194738","title":"Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)","has_exemption":false,"start_date":"2014-09-26","completion_date":"2026-09-28","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05336695","publication_url":"https://clinicaltrials.gov/study/NCT05336695","title":"Assess the Brain Levels of Fibrin in Alzheimer's Disease and Its Related Dementias Subjects Using 64Cu-FBP8 PET","has_exemption":false,"start_date":"2022-03-29","completion_date":"2026-09-28","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05956626","publication_url":"https://clinicaltrials.gov/study/NCT05956626","title":"A PHASE 1 STUDY TO ASSESS THE SAFETY AND EFFICACY OF OCU410ST FOR STARGARDT DISEASE AND PHASE 2/3 PIVOTAL CONFIRMATORY CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF OCU410ST FOR STARGARDT DISEASE","has_exemption":false,"start_date":"2023-08-25","completion_date":"2026-09-28","has_results":false,"results_due":false,"sponsor_name":"Ocugen","sponsor_slug":"ocugen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05705024","publication_url":"https://clinicaltrials.gov/study/NCT05705024","title":"Efficacy of Locally Delivered Allogeneic Mesenchymal Stem Cells for Promoting Corneal Repair","has_exemption":false,"start_date":"2023-09-29","completion_date":"2026-09-28","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05888844","publication_url":"https://clinicaltrials.gov/study/NCT05888844","title":"A Phase 2 Study Evaluating INCB099280 in Participants With Advanced Squamous Cell Carcinoma","has_exemption":false,"start_date":"2023-10-09","completion_date":"2026-09-28","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04577014","publication_url":"https://clinicaltrials.gov/study/NCT04577014","title":"A Multi-cohort Study of Retifanlimab With or Without Gemcitabine and Docetaxel in Patients With Advanced Sarcoma","has_exemption":false,"start_date":"2020-09-29","completion_date":"2026-09-29","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05263934","publication_url":"https://clinicaltrials.gov/study/NCT05263934","title":"A 52-week, Randomized, Double-blind, Double-dummy, Parallel-group, Multi-centre, Non-inferiority Study to Investigate the Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) Receiving Standard of Care (SoC) Therapy","has_exemption":false,"start_date":"2022-07-14","completion_date":"2026-09-29","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05392946","publication_url":"https://clinicaltrials.gov/study/NCT05392946","title":"Phase 1/2 Trial of Iberdomide in Combination With Daratumumab, BortEzomib and DexamethAsone in Patients With Newly Diagnosed Multiple MyeLoma (IDEAL)","has_exemption":false,"start_date":"2022-08-11","completion_date":"2026-09-29","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04217603","publication_url":"https://clinicaltrials.gov/study/NCT04217603","title":"Effect of Continuous Positive Airway Pressure (CPAP) on 6-Minute Walk Test Outcomes in Patients With Excessive Central Airway Collapse (ECAC)","has_exemption":false,"start_date":"2023-03-01","completion_date":"2026-09-29","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06943404","publication_url":"https://clinicaltrials.gov/study/NCT06943404","title":"Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With a Sublingual Formulation of Dexmedetomidine (BXCL501)","has_exemption":false,"start_date":"2026-02-23","completion_date":"2026-09-29","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07555483","publication_url":"https://clinicaltrials.gov/study/NCT07555483","title":"An Open-Label, Multicenter, Randomized, Non-Inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Weekly Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Patients With Alpha1-Antitrypsin Deficiency Compared to Corresponding Standard 60 mg/kg/Week and 120 mg/kg/Week Doses of Intravenous Alpha1-Proteinase Inhibitor (5%)","has_exemption":false,"start_date":"2026-04-21","completion_date":"2026-09-29","has_results":false,"results_due":false,"sponsor_name":"Grifols Therapeutics LLC","sponsor_slug":"grifols-therapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00179465","publication_url":"https://clinicaltrials.gov/study/NCT00179465","title":"Addition of Tiagabine to Second-Generation Antipsychotics in the Treatment of Recent-Onset Schizophrenia by Modification of Developmental Reorganization of the Prefrontal Cortex","has_exemption":false,"start_date":"2003-11-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00525720","publication_url":"https://clinicaltrials.gov/study/NCT00525720","title":"Transperineal Interstitial Permanent Brachytherapy Alone for Selected Patients With Intermediate Risk Prostatic Carcinoma","has_exemption":false,"start_date":"2006-08-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00734877","publication_url":"https://clinicaltrials.gov/study/NCT00734877","title":"UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma Ages 65 and Under: A Trial Enrolling Subjects to Standard Total Therapy 3 (S-TT3)","has_exemption":false,"start_date":"2008-07-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01203839","publication_url":"https://clinicaltrials.gov/study/NCT01203839","title":"A Phase II Study of Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer","has_exemption":false,"start_date":"2010-09-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01410942","publication_url":"https://clinicaltrials.gov/study/NCT01410942","title":"Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy","has_exemption":false,"start_date":"2012-02-08","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01688492","publication_url":"https://clinicaltrials.gov/study/NCT01688492","title":"A Phase 2 Study Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer","has_exemption":false,"start_date":"2012-09-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01709292","publication_url":"https://clinicaltrials.gov/study/NCT01709292","title":"Pharmacodynamic Study of Vemurafenib in the Neoadjuvant Setting in Patients With Locally Advanced Thyroid Cancer","has_exemption":false,"start_date":"2012-11-07","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01815359","publication_url":"https://clinicaltrials.gov/study/NCT01815359","title":"ICARuS (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multi-center, Randomized Phase II Trial of Early Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis","has_exemption":false,"start_date":"2013-03-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02122562","publication_url":"https://clinicaltrials.gov/study/NCT02122562","title":"Functional Neuroimaging of the Enhanced Antidepressant Efficacy of Ketamine in a Biologically-Enriched Subgroup","has_exemption":false,"start_date":"2014-04-23","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mark Niciu","sponsor_slug":"mark-niciu","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02138734","publication_url":"https://clinicaltrials.gov/study/NCT02138734","title":"A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2014-07-21","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"ImmunityBio, Inc.","sponsor_slug":"immunitybio-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02176967","publication_url":"https://clinicaltrials.gov/study/NCT02176967","title":"Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma","has_exemption":false,"start_date":"2014-08-08","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02131584","publication_url":"https://clinicaltrials.gov/study/NCT02131584","title":"Administration of Jakafi (Ruxolitinib) for Symptom Control of Patients With Chronic Lymphocytic Leukemia (CLL): A Phase II Study","has_exemption":false,"start_date":"2014-09-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05708911","publication_url":"https://clinicaltrials.gov/study/NCT05708911","title":"Impact of External Pharyngeal Exerciser on Pharyngeal Phase of Swallowing","has_exemption":false,"start_date":"2014-09-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02444741","publication_url":"https://clinicaltrials.gov/study/NCT02444741","title":"Phase I/II Trial of MK-3475 and Hypofractionated Stereotactic Radiation Therapy in Patients With NSCLC","has_exemption":false,"start_date":"2015-09-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02397083","publication_url":"https://clinicaltrials.gov/study/NCT02397083","title":"Phase II Study of the Levonorgestrel Intrauterine Device Alone or in Combination With the mTORC1 Inhibitor, Everolimus, for the Treatment of Complex Atypical Hyperplasia and Stage Ia Grade 1 Endometrial Cancer","has_exemption":false,"start_date":"2015-09-23","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02736656","publication_url":"https://clinicaltrials.gov/study/NCT02736656","title":"Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of SPN-812 for the Treatment of Pediatric Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)","has_exemption":false,"start_date":"2016-02-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Supernus Pharmaceuticals, Inc.","sponsor_slug":"supernus-pharmaceuticals-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02849223","publication_url":"https://clinicaltrials.gov/study/NCT02849223","title":"Transcranial Direct Current Stimulation (TDCS) as an Intervention for Patients With Traumatic Brain Injury","has_exemption":false,"start_date":"2016-07-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Minneapolis Veterans Affairs Medical Center","sponsor_slug":"minneapolis-veterans-affairs-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02847559","publication_url":"https://clinicaltrials.gov/study/NCT02847559","title":"A Phase 2, Single Arm, Multi-center, Open Label Trial Combining Optune With Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma","has_exemption":false,"start_date":"2016-08-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02932150","publication_url":"https://clinicaltrials.gov/study/NCT02932150","title":"A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Children and Adolescent Subjects With Chronic Hepatitis B Virus Infection","has_exemption":false,"start_date":"2016-11-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02914535","publication_url":"https://clinicaltrials.gov/study/NCT02914535","title":"A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects With Ulcerative Colitis","has_exemption":false,"start_date":"2017-02-23","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Alfasigma S.p.A.","sponsor_slug":"alfasigma-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03094429","publication_url":"https://clinicaltrials.gov/study/NCT03094429","title":"An Adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®,a D-Amino Acid Oxidase Inhibitor, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults","has_exemption":false,"start_date":"2017-03-29","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"SyneuRx International (Taiwan) Corp","sponsor_slug":"syneurx-international-taiwan-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03117751","publication_url":"https://clinicaltrials.gov/study/NCT03117751","title":"Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma","has_exemption":false,"start_date":"2017-03-29","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03125642","publication_url":"https://clinicaltrials.gov/study/NCT03125642","title":"Autologous Stem Cell Transplant In Patients With Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphomas (NHL)","has_exemption":false,"start_date":"2017-04-20","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03282344","publication_url":"https://clinicaltrials.gov/study/NCT03282344","title":"A Pilot Study of NKTR-214 and Nivolumab in Selected Patients With Locally Advanced/Metastatic Sarcoma (CA209-9EM)","has_exemption":false,"start_date":"2017-09-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05370287","publication_url":"https://clinicaltrials.gov/study/NCT05370287","title":"Adaptive Optics Retinal Imaging","has_exemption":false,"start_date":"2018-01-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Food and Drug Administration (FDA)","sponsor_slug":"food-and-drug-administration-fda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03392324","publication_url":"https://clinicaltrials.gov/study/NCT03392324","title":"Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Atrophic Dry Age Related Macular Degeneration","has_exemption":false,"start_date":"2018-04-26","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Science Corporation","sponsor_slug":"science-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03571568","publication_url":"https://clinicaltrials.gov/study/NCT03571568","title":"Phase 1/2a Trial of BI-1206, a Monoclonal Antibody to CD32b (FcyRIIB), in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell Non-Hodgkin Lymphoma That Has Relapsed or is Refractory to Rituximab","has_exemption":false,"start_date":"2018-05-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"BioInvent International AB","sponsor_slug":"bioinvent-international-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03544632","publication_url":"https://clinicaltrials.gov/study/NCT03544632","title":"A Phase II, Dose-escalation, Open-label Study Evaluating the Safety and Efficacy of Permanently-placed Acellular Adipose Tissue (AAT) in Human Subjects With Modest Soft Tissue Defects of the Trunk","has_exemption":false,"start_date":"2018-06-21","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03582124","publication_url":"https://clinicaltrials.gov/study/NCT03582124","title":"A Phase I/II Study Evaluating the Safety and Pharmacokinetics of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Lung Cancer During Surgical Procedures","has_exemption":false,"start_date":"2018-07-19","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03286868","publication_url":"https://clinicaltrials.gov/study/NCT03286868","title":"Balancing Kinematically Aligned Total Knee Replacements During Total Primary Knee Arthroplasty Using Verasense","has_exemption":false,"start_date":"2018-07-23","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Nova Scotia Health Authority","sponsor_slug":"nova-scotia-health-authority","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03573648","publication_url":"https://clinicaltrials.gov/study/NCT03573648","title":"A Pilot Study of IMMUNe mOdulation in Early Stage Estrogen Receptor Positive Breast Cancer Treated With neoADjuvant Avelumab, Palbociclib, and Endocrine Therapy: The ImmunoADAPT Study","has_exemption":false,"start_date":"2018-11-13","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03823144","publication_url":"https://clinicaltrials.gov/study/NCT03823144","title":"Intravital Microscopy (IVM) in Human Solid Tumors","has_exemption":false,"start_date":"2019-02-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03401398","publication_url":"https://clinicaltrials.gov/study/NCT03401398","title":"Stress Hydrocortisone In Pediatric Septic Shock","has_exemption":false,"start_date":"2019-03-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Jerry Zimmerman","sponsor_slug":"jerry-zimmerman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03104517","publication_url":"https://clinicaltrials.gov/study/NCT03104517","title":"CELLEBRATE: A Double-Blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Persistent or Recurrent Stress Urinary Incontinence Following Surgical Treatment","has_exemption":false,"start_date":"2019-04-23","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Cook MyoSite","sponsor_slug":"cook-myosite","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03740204","publication_url":"https://clinicaltrials.gov/study/NCT03740204","title":"The Role of Estrogen in the Neurobiology of Eating Disorders: A Study of Cognitive Flexibility and Reward in Eating Disorders","has_exemption":false,"start_date":"2019-06-13","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03492671","publication_url":"https://clinicaltrials.gov/study/NCT03492671","title":"A Phase II Trial of Pre-operative Chemotherapy (With Gemcitabine and Nab- Paclitaxel) and Stereotactic Body Radiotherapy Followed by Surgery and Chemotherapy in Patients With Resectable Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2019-07-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Loma Linda University","sponsor_slug":"loma-linda-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04074356","publication_url":"https://clinicaltrials.gov/study/NCT04074356","title":"Non-invasive Markers of Esophageal Function in Adults","has_exemption":false,"start_date":"2019-09-04","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04099992","publication_url":"https://clinicaltrials.gov/study/NCT04099992","title":"Sympatho-inhibition With Mindfulness in Chronic Kidney Disease (MIND-CKD)","has_exemption":false,"start_date":"2019-09-20","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04106414","publication_url":"https://clinicaltrials.gov/study/NCT04106414","title":"A Phase II Trial of IDO-Inhibitor, BMS-986205, and PD-1 Inhibitor, Nivolumab, in Patients With Recurrent or Persistent Endometrial Cancer or Endometrial Carcinosarcomas (CA017-056)","has_exemption":false,"start_date":"2019-09-24","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04130464","publication_url":"https://clinicaltrials.gov/study/NCT04130464","title":"The Impact of the Continuous Infusion of Intraperitoneal Analgesics on Postoperative Pain After Minimally Invasive Hysterectomy: a Randomized Controlled Trial","has_exemption":false,"start_date":"2019-09-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Ying Liu","sponsor_slug":"ying-liu","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04221997","publication_url":"https://clinicaltrials.gov/study/NCT04221997","title":"Extracellular Vesicles as Predictors of Antidepressant Outcomes in Pediatric Anxiety (EV-SOPRANO)","has_exemption":false,"start_date":"2019-11-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04115306","publication_url":"https://clinicaltrials.gov/study/NCT04115306","title":"Ph 1/1b/2 Multicenter, Open-Label, FIH Dose Esc & Dose Exp Study to Assess Safety and Tolerability of Orally Administered PMD-026 as a Single Agent and in Combination in Patients With Metastatic or Locally Advanced (Inoperable) RSK2+ Breast Cancer","has_exemption":false,"start_date":"2019-11-14","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Phoenix Molecular Designs","sponsor_slug":"phoenix-molecular-designs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04238143","publication_url":"https://clinicaltrials.gov/study/NCT04238143","title":"Adipose-Derived Biocellular Regenerative Therapy in Treatment of Osteoarthritis (OA) and Associated Connective Tissue Degeneration and Pain","has_exemption":false,"start_date":"2020-01-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Healeon Medical Inc","sponsor_slug":"healeon-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04323735","publication_url":"https://clinicaltrials.gov/study/NCT04323735","title":"Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters","has_exemption":false,"start_date":"2020-01-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Medstar Health Research Institute","sponsor_slug":"medstar-health-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04088396","publication_url":"https://clinicaltrials.gov/study/NCT04088396","title":"Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.","has_exemption":false,"start_date":"2020-02-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04094610","publication_url":"https://clinicaltrials.gov/study/NCT04094610","title":"A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations","has_exemption":false,"start_date":"2020-03-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Turning Point Therapeutics, Inc.","sponsor_slug":"turning-point-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04253964","publication_url":"https://clinicaltrials.gov/study/NCT04253964","title":"Phase II Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-Small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy","has_exemption":false,"start_date":"2020-07-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04167358","publication_url":"https://clinicaltrials.gov/study/NCT04167358","title":"Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis","has_exemption":false,"start_date":"2020-07-14","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04476953","publication_url":"https://clinicaltrials.gov/study/NCT04476953","title":"COVID-FISETIN: A Phase 2 Placebo-Controlled Pilot Study in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Excessive Inflammatory Response in Hospitalized Adults","has_exemption":false,"start_date":"2020-08-03","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04477629","publication_url":"https://clinicaltrials.gov/study/NCT04477629","title":"Belatacept in De Novo Heart Transplantation - Pilot Study","has_exemption":false,"start_date":"2020-08-06","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03245541","publication_url":"https://clinicaltrials.gov/study/NCT03245541","title":"A Phase I/II Study of Durvalumab (Medi 4736) and Stereotactic Ablative Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2020-08-14","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04331275","publication_url":"https://clinicaltrials.gov/study/NCT04331275","title":"Viral Specific T-cells (VSTs) for Treatment of Viral Infections After Solid Organ Transplant","has_exemption":false,"start_date":"2020-08-18","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04508049","publication_url":"https://clinicaltrials.gov/study/NCT04508049","title":"Quantitative Magnetization Transfer MRI for Evaluation of Renal Fibrosis","has_exemption":false,"start_date":"2020-10-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04580472","publication_url":"https://clinicaltrials.gov/study/NCT04580472","title":"Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery","has_exemption":false,"start_date":"2020-10-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Carilion Clinic","sponsor_slug":"carilion-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04599036","publication_url":"https://clinicaltrials.gov/study/NCT04599036","title":"Myoelectrolytically Controlled Device in Acute Rehabilitation After Stroke","has_exemption":false,"start_date":"2020-10-07","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04221815","publication_url":"https://clinicaltrials.gov/study/NCT04221815","title":"IMPact on Revascularization Outcomes of intraVascular Ultrasound Guided Treatment of Complex Lesions and Economic Impact (IMPROVE)","has_exemption":false,"start_date":"2020-10-14","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Medstar Health Research Institute","sponsor_slug":"medstar-health-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04045093","publication_url":"https://clinicaltrials.gov/study/NCT04045093","title":"Rationale and Design of Dabigatran for Mitral Stenosis Atrial Fibrillation Trial","has_exemption":false,"start_date":"2020-10-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"The University of Hong Kong","sponsor_slug":"the-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04412629","publication_url":"https://clinicaltrials.gov/study/NCT04412629","title":"Cabozantinib in High Grade Neuroendocrine Neoplasms","has_exemption":false,"start_date":"2020-11-24","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04500041","publication_url":"https://clinicaltrials.gov/study/NCT04500041","title":"Casting vs Bracing for Idiopathic Early-Onset Scoliosis","has_exemption":false,"start_date":"2021-02-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04748601","publication_url":"https://clinicaltrials.gov/study/NCT04748601","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 4 Study to Evaluate the Efficacy and Safety of Qudexy(R) XR in the Prevention of Migraine in Children 6 to 11 Years of Age","has_exemption":false,"start_date":"2021-02-19","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Upsher-Smith Laboratories","sponsor_slug":"upsher-smith-laboratories","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04562870","publication_url":"https://clinicaltrials.gov/study/NCT04562870","title":"A Phase 2, Randomized, Open-Label, Multicenter Study to Evaluate Safety and Efficacy of Single Agent Selinexor Versus Treatment of Physician's Choice in Patients With Previously Treated Myelofibrosis","has_exemption":false,"start_date":"2021-03-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Karyopharm Therapeutics Inc","sponsor_slug":"karyopharm-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04641702","publication_url":"https://clinicaltrials.gov/study/NCT04641702","title":"Comprehensive Assessment of Histopathologic and Physiologic Profile in Esophageal Motility Disorders","has_exemption":false,"start_date":"2021-03-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03826693","publication_url":"https://clinicaltrials.gov/study/NCT03826693","title":"Efficacy of Nitrous Oxide in OCD: Pilot Study","has_exemption":false,"start_date":"2021-04-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04868838","publication_url":"https://clinicaltrials.gov/study/NCT04868838","title":"A Phase 2 Open-label Trial Evaluating the Efficacy and Safety of Daratumumab in Treatment of Patients With Active Lupus Nephritis","has_exemption":false,"start_date":"2021-04-20","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04046900","publication_url":"https://clinicaltrials.gov/study/NCT04046900","title":"Vaginal Microbiota Transplant to Promote Lactobacillus-dominant Cervicovaginal Communities","has_exemption":false,"start_date":"2021-04-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Douglas Kwon","sponsor_slug":"douglas-kwon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04678154","publication_url":"https://clinicaltrials.gov/study/NCT04678154","title":"Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT - A Multicenter Randomized Control Trial","has_exemption":false,"start_date":"2021-05-07","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Major Extremity Trauma Research Consortium","sponsor_slug":"major-extremity-trauma-research-consortium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04718168","publication_url":"https://clinicaltrials.gov/study/NCT04718168","title":"GORE® ENFORM Biomaterial Product Study: A Study to Describe Multi-use Biomaterial Performance in Hernia Patients","has_exemption":false,"start_date":"2021-05-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"W.L.Gore & Associates","sponsor_slug":"wlgore-associates","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04895241","publication_url":"https://clinicaltrials.gov/study/NCT04895241","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care","has_exemption":false,"start_date":"2021-05-25","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04855253","publication_url":"https://clinicaltrials.gov/study/NCT04855253","title":"Phase I/II Trial Using E7777 to Enhance Regulatory T-Cell Depletion Prior to CAR-T Therapy for Relapsed/Refractory Large B-Cell Lymphomas","has_exemption":false,"start_date":"2021-06-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05028621","publication_url":"https://clinicaltrials.gov/study/NCT05028621","title":"Exploratory Analysis of the Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease","has_exemption":false,"start_date":"2021-06-18","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04647227","publication_url":"https://clinicaltrials.gov/study/NCT04647227","title":"Safety of SEVENFACT® for the Treatment of Bleeding Events in Patients With Hemophilia A or B With Inhibitors","has_exemption":false,"start_date":"2021-06-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"American Thrombosis and Hemostasis Network","sponsor_slug":"american-thrombosis-and-hemostasis-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04892953","publication_url":"https://clinicaltrials.gov/study/NCT04892953","title":"Local Consolidative Therapy (LCT) and Durvalumab (MEDI4736) for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy (ENDURE)","has_exemption":false,"start_date":"2021-07-07","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04575688","publication_url":"https://clinicaltrials.gov/study/NCT04575688","title":"A Randomized Controlled Trial Comparing a Periarticular Injection to a Popliteal Block for Pain Control in Ankle/Hindfoot Osteotomy or Fusion and Ankle Fractures","has_exemption":false,"start_date":"2021-07-13","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Campbell Clinic","sponsor_slug":"campbell-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04869059","publication_url":"https://clinicaltrials.gov/study/NCT04869059","title":"Treatment of Verbal Retrieval Deficits in Mild Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation","has_exemption":false,"start_date":"2021-08-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Dallas","sponsor_slug":"the-university-of-texas-at-dallas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04399941","publication_url":"https://clinicaltrials.gov/study/NCT04399941","title":"Role of Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis","has_exemption":false,"start_date":"2021-08-03","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Boston Medical Center","sponsor_slug":"boston-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05852730","publication_url":"https://clinicaltrials.gov/study/NCT05852730","title":"Optimizing the Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance. Motion Sickness Countermeasures Field Test","has_exemption":false,"start_date":"2021-08-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Repurposed Therapeutics, Inc.","sponsor_slug":"repurposed-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04868604","publication_url":"https://clinicaltrials.gov/study/NCT04868604","title":"A Phase I/IIa Theranostic Study of 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer","has_exemption":false,"start_date":"2021-08-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Clarity Pharmaceuticals Ltd","sponsor_slug":"clarity-pharmaceuticals-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04706923","publication_url":"https://clinicaltrials.gov/study/NCT04706923","title":"A Phase IIa, Open-label, Multiple Ascending Dose Confirmation Study of the Safety and Tolerability of Intravenous Administration of Brincidofovir in Subjects With Adenovirus Infection or Cytomegalovirus Infection","has_exemption":false,"start_date":"2021-08-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"SymBio Pharmaceuticals","sponsor_slug":"symbio-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04679012","publication_url":"https://clinicaltrials.gov/study/NCT04679012","title":"Phase II Study of Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation","has_exemption":false,"start_date":"2021-09-24","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05059522","publication_url":"https://clinicaltrials.gov/study/NCT05059522","title":"Avelumab Master Protocol: An Open-label Continuation Study for Participants Continuing From Pfizer-sponsored Avelumab Clinical Studies.","has_exemption":false,"start_date":"2021-09-29","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04835506","publication_url":"https://clinicaltrials.gov/study/NCT04835506","title":"Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial","has_exemption":false,"start_date":"2021-11-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04979338","publication_url":"https://clinicaltrials.gov/study/NCT04979338","title":"Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries","has_exemption":false,"start_date":"2021-11-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05004987","publication_url":"https://clinicaltrials.gov/study/NCT05004987","title":"Depression Treatment and Aβ Dynamics: A Study of Alzheimer's Disease Risk (ABD Study)","has_exemption":false,"start_date":"2022-02-04","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05069038","publication_url":"https://clinicaltrials.gov/study/NCT05069038","title":"A Phase II Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy for Post and Pre-menopausal Patients With Early Stage Hormone Receptor Positive and Her-2/Neu Negative Breast Cancer","has_exemption":false,"start_date":"2022-03-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05315700","publication_url":"https://clinicaltrials.gov/study/NCT05315700","title":"An Open-Label, Phase 1/2 Study of ORIC-114 as a Single Agent or in Combination With Chemotherapy, in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration","has_exemption":false,"start_date":"2022-03-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"ORIC Pharmaceuticals","sponsor_slug":"oric-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04980222","publication_url":"https://clinicaltrials.gov/study/NCT04980222","title":"A Phase II Study Evaluating the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma","has_exemption":false,"start_date":"2022-03-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05444751","publication_url":"https://clinicaltrials.gov/study/NCT05444751","title":"Evaluating General Anesthesia With Erector Spinae Plane Block vs. Spinal Anesthesia With Erector Spinae Plane Block in Lumbar Decompression Surgeries","has_exemption":false,"start_date":"2022-03-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05101746","publication_url":"https://clinicaltrials.gov/study/NCT05101746","title":"Nitric Oxide Administration During Pediatric Cardiopulmonary Bypass Effects on End Organ Damage to the Brain and Kidney","has_exemption":false,"start_date":"2022-04-25","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04481919","publication_url":"https://clinicaltrials.gov/study/NCT04481919","title":"A Randomized Trial of Protocolized Diuretic Therapy Compared to Standard Care in Emergency Department Patients With Acute Heart Failure","has_exemption":false,"start_date":"2022-05-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727942","publication_url":"https://clinicaltrials.gov/study/NCT06727942","title":"Toward Healthy Living: Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes","has_exemption":false,"start_date":"2022-05-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Arlington","sponsor_slug":"the-university-of-texas-at-arlington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05186974","publication_url":"https://clinicaltrials.gov/study/NCT05186974","title":"An Open-label, Multicenter, Phase 2 Study of Sacituzumab Govitecan Combinations in First-line Treatment of Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) Without Actionable Genomic Alterations","has_exemption":false,"start_date":"2022-05-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05320198","publication_url":"https://clinicaltrials.gov/study/NCT05320198","title":"RALLY-MF: A Phase 1b/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of DISC-0974 in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia","has_exemption":false,"start_date":"2022-06-06","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Disc Medicine, Inc","sponsor_slug":"disc-medicine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05020028","publication_url":"https://clinicaltrials.gov/study/NCT05020028","title":"The Use of Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis. A Double-Blind, Randomized Control Study","has_exemption":false,"start_date":"2022-06-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05113368","publication_url":"https://clinicaltrials.gov/study/NCT05113368","title":"Efficacy of Oral Regorafenib Combined With Intra-muscular Injection of Fulvestrant in Patients With Recurrent Low-grade Serous Ovarian Cancer: A Phase II Single Arm Trial","has_exemption":false,"start_date":"2022-06-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Sarah K. Lynam MD","sponsor_slug":"sarah-k-lynam-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05318105","publication_url":"https://clinicaltrials.gov/study/NCT05318105","title":"A Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Aquadex System in Patients With Heart Failure and Fluid Overload","has_exemption":false,"start_date":"2022-06-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Nuwellis, Inc.","sponsor_slug":"nuwellis-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05303064","publication_url":"https://clinicaltrials.gov/study/NCT05303064","title":"A Phase 3, Randomized, Double-Blind, 52-Week Study of OLZ/SAM vs Olanzapine to Evaluate Weight Gain as Assessed by Change in BMI Z-Score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder (ENLIGHTEN-Youth)","has_exemption":false,"start_date":"2022-06-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Alkermes, Inc.","sponsor_slug":"alkermes-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04066348","publication_url":"https://clinicaltrials.gov/study/NCT04066348","title":"Clinical Trial of Etanercept (TNF-α Blocker) for Treatment of Blast-Induced Tinnitus","has_exemption":false,"start_date":"2022-07-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Wayne State University","sponsor_slug":"wayne-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05308446","publication_url":"https://clinicaltrials.gov/study/NCT05308446","title":"Randomized Phase II Trial of Encorafenib and Cetuximab With or Without Nivolumab (NSC #748726) for Patients With Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer","has_exemption":false,"start_date":"2022-07-19","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05322850","publication_url":"https://clinicaltrials.gov/study/NCT05322850","title":"Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT) Recipients With Hematologic Malignancies (HM)","has_exemption":false,"start_date":"2022-08-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05534321","publication_url":"https://clinicaltrials.gov/study/NCT05534321","title":"Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease (PROMISSeD Trial)","has_exemption":false,"start_date":"2022-08-29","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Baptist Health South Florida","sponsor_slug":"baptist-health-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05566574","publication_url":"https://clinicaltrials.gov/study/NCT05566574","title":"RP-3500 (ATRi) + External Beam Radiotherapy (EBRT) for the Palliative Treatment of Metastatic Disease","has_exemption":false,"start_date":"2022-09-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05254314","publication_url":"https://clinicaltrials.gov/study/NCT05254314","title":"Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-related, Symptomatic Asthma (GATA-3)","has_exemption":false,"start_date":"2022-10-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05451771","publication_url":"https://clinicaltrials.gov/study/NCT05451771","title":"An Open-label Phase I/II Trial of Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Systemic Light-Chain Amyloidosis","has_exemption":false,"start_date":"2022-10-26","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Rajshekhar Chakraborty, MD","sponsor_slug":"rajshekhar-chakraborty-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05519683","publication_url":"https://clinicaltrials.gov/study/NCT05519683","title":"Effects of Home-based TEA for Abdominal Pain in Patients With Irritable Bowel Syndrome (IBS)","has_exemption":false,"start_date":"2022-11-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05291091","publication_url":"https://clinicaltrials.gov/study/NCT05291091","title":"A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of EDG-5506 on Safety, Biomarkers, Pharmacokinetics, and Functional Measures in Adults and Adolescents With Becker Muscular Dystrophy","has_exemption":false,"start_date":"2022-11-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Edgewise Therapeutics, Inc.","sponsor_slug":"edgewise-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05407324","publication_url":"https://clinicaltrials.gov/study/NCT05407324","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety and Efficacy of CORT113176 (Dazucorilant) in Patients With Amyotrophic Lateral Sclerosis (DAZALS)","has_exemption":false,"start_date":"2022-11-15","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Corcept Therapeutics","sponsor_slug":"corcept-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03953144","publication_url":"https://clinicaltrials.gov/study/NCT03953144","title":"Synapse 3D With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial: A Phase I Safety and Feasibility Trial","has_exemption":false,"start_date":"2022-12-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"St. Joseph's Healthcare Hamilton","sponsor_slug":"st-josephs-healthcare-hamilton","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669950","publication_url":"https://clinicaltrials.gov/study/NCT05669950","title":"A Multi-site, Open-label, Sequential-group, Multiple-dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia","has_exemption":false,"start_date":"2022-12-19","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"H. Lundbeck A/S","sponsor_slug":"h-lundbeck-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05592002","publication_url":"https://clinicaltrials.gov/study/NCT05592002","title":"A Multicenter Study to Assess the Safety and Effectiveness of the Genio® Dual-sided Hypoglossal Nerve Stimulation System for the Treatment of Obstructive Sleep Apnea in Subjects With Complete Concentric Collapse of the Soft Palate.","has_exemption":false,"start_date":"2022-12-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Nyxoah S.A.","sponsor_slug":"nyxoah-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05443685","publication_url":"https://clinicaltrials.gov/study/NCT05443685","title":"An Open-Label, Phase 1/2, Single-Site Study of the Safety, Biochemical Efficacy, and Exploratory Clinical Effects of Oral ADX-629 in Subjects With Sjögren-Larsson Syndrome","has_exemption":false,"start_date":"2023-01-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05499013","publication_url":"https://clinicaltrials.gov/study/NCT05499013","title":"Phase 1/2 Study With an Open-label Dose Escalation Phase Followed by a Randomized, Double-blind Phase of SLN124 in Patients With Polycythemia Vera","has_exemption":false,"start_date":"2023-01-26","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Silence Therapeutics plc","sponsor_slug":"silence-therapeutics-plc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05536804","publication_url":"https://clinicaltrials.gov/study/NCT05536804","title":"Tirzepatide Study of Renal Function in People With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes: Focus on Kidney Hypoxia in Relation to Fatty Kidney Disease Using Multiparametric Magnetic Resonance Imaging","has_exemption":false,"start_date":"2023-02-08","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06078878","publication_url":"https://clinicaltrials.gov/study/NCT06078878","title":"Clinical Feasibility Evaluation of the Gentuity HF-OCT Imaging System With Vis-M Micro-Imaging Catheter","has_exemption":false,"start_date":"2023-02-13","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Gentuity, LLC","sponsor_slug":"gentuity-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05462145","publication_url":"https://clinicaltrials.gov/study/NCT05462145","title":"A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation","has_exemption":false,"start_date":"2023-03-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Kardium Inc.","sponsor_slug":"kardium-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05766254","publication_url":"https://clinicaltrials.gov/study/NCT05766254","title":"Identify the Optimal TMS Target to Modulate Midcingulate Reward Activity in Smokers","has_exemption":false,"start_date":"2023-03-24","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05835999","publication_url":"https://clinicaltrials.gov/study/NCT05835999","title":"Clinical Evaluation of mTORC1 Inhibition for Geroprotection","has_exemption":false,"start_date":"2023-03-24","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05346809","publication_url":"https://clinicaltrials.gov/study/NCT05346809","title":"Randomized Phase 2 Trial of Isatuximab During Autologous Stem Cell Collection and Transplantation Period in Patients With Multiple Myeloma, Relapsed Hodgkin's and Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2023-03-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Divaya Bhutani","sponsor_slug":"divaya-bhutani","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05838729","publication_url":"https://clinicaltrials.gov/study/NCT05838729","title":"Phase 1b/2a Study of RiMO-301 and Hypofractionated Radiotherapy With A PD-1 Inhibitor for the Treatment of Unresectable, Recurrent or Metastatic Head-Neck Cancer","has_exemption":false,"start_date":"2023-04-03","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Coordination Pharmaceuticals, Inc.","sponsor_slug":"coordination-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672901","publication_url":"https://clinicaltrials.gov/study/NCT05672901","title":"Comparison of a Novel Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause: a Non-inferiority Trial","has_exemption":false,"start_date":"2023-04-04","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Stratpharma AG","sponsor_slug":"stratpharma-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05801978","publication_url":"https://clinicaltrials.gov/study/NCT05801978","title":"Systems Biological Assessment of the Durability of Vaccine Responses","has_exemption":false,"start_date":"2023-04-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05850689","publication_url":"https://clinicaltrials.gov/study/NCT05850689","title":"A Randomized, Double-Blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder","has_exemption":false,"start_date":"2023-05-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05514106","publication_url":"https://clinicaltrials.gov/study/NCT05514106","title":"Myocardial 123I-MIBG Scintigraphy in Aging and Neurodegenerative Disease","has_exemption":false,"start_date":"2023-05-08","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05740176","publication_url":"https://clinicaltrials.gov/study/NCT05740176","title":"A Multi-Center, Prospective, Historically Controlled Pivotal Trial Comparing the Safety and Effectiveness of the Synergy Disc to Anterior Cervical Discectomy and Fusion in Patients With Two-Level Symptomatic Cervical Degenerative Disc Disease (DDD)","has_exemption":false,"start_date":"2023-06-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Synergy Spine Solutions","sponsor_slug":"synergy-spine-solutions","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05888831","publication_url":"https://clinicaltrials.gov/study/NCT05888831","title":"A Phase 1/2 Study of BMS-986449 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-06-06","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05857930","publication_url":"https://clinicaltrials.gov/study/NCT05857930","title":"A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess the Efficacy and Safety of Daily OM-85 Treatment vs. Placebo Given in Children Aged 6 Months to 5 Years With Recurrent Wheezing","has_exemption":false,"start_date":"2023-06-20","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"OM Pharma SA","sponsor_slug":"om-pharma-sa","status":"ongoing","is_pact":false,"days_late":null}]}